Compare Twist Bioscience Corp (TWST) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs US Bancorp — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 18× Twist Bioscience Corp's market cap, and US Bancorp pays a 3.29% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | USB | |
|---|---|---|
Market Cap | $5.45B | $98.36B |
Sector | Health | Financials |
52-Week High | $102.88 | $64.01 |
52-Week Low | $24.16 | $43.94 |
Enterprise Value | $5.37B | — |
Dividend Yield | — | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
